Beijing, China

Jianrui Li


 

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2019-2024

Loading Chart...
Loading Chart...
2 patents (USPTO):

Title: Innovations in Antiviral Compounds by Jianrui Li

Introduction

Jianrui Li is a prominent inventor based in Beijing, China. He has made significant contributions to the field of antiviral research, holding a total of 2 patents. His work focuses on developing novel compounds that exhibit antiviral properties, which are crucial in combating various viral infections.

Latest Patents

One of Jianrui Li's latest patents is titled "Phenylmethyl-piperazine derivatives and antiviral uses thereof." This invention discloses a benzyl piperazine compound, along with its preparation method and application in antiviral treatments. Experimental results have shown that this compound not only possesses significant antiviral activity but also demonstrates low cytotoxicity and a high selectivity index. Another notable patent involves a new aromatic cyanogen compound, which is also aimed at antiviral drug development, particularly for anti-HCV drugs.

Career Highlights

Jianrui Li is affiliated with the Chinese Academy of Medical Sciences, where he conducts his research and development activities. His work has been instrumental in advancing the understanding and treatment of viral infections through innovative compounds.

Collaborations

Jianrui Li collaborates with several esteemed colleagues, including Yanping Li and Zhuorong Li. Their combined expertise enhances the research efforts in the field of antiviral compounds.

Conclusion

Jianrui Li's contributions to antiviral research through his innovative patents highlight the importance of developing effective treatments for viral infections. His work continues to pave the way for advancements in medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…